~~<i id='FA713B6260'><strike id='FA713B6260'><tt id='FA713B6260'><pre id='FA713B6260'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：fashion 2025-10-02 11:38:09 - browse：6851

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Dewpoint Therapeutics lays off staff after losing partnerships

focus

explore

focus

knowledge

Wikipedia

AdobeIfyouhaveacough,fever,orshortnessofbreath,howcanyoutellifyou’vegotCovid-19,acommoncold,theordin

WSS

CEOs share strategies for surviving biotech slump

Independent physicians launch a new lobbying group

Why health workers in Gaza are injured or die at high rates

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

HHS leader on health, climate change and biopharma emissions

AI generated plenty of interest at JPM but not a lot of trust

hotspot

fashion

focus

Wildfire smoke exposes gaps in outdoor worker protections

STAT Summit: How a Chicago ER doctor tackles gun violence

Supreme Court strikes down use of affirmative action

Think you might have Covid

Medicare details structure of new drug price negotiation program

Dewpoint Therapeutics lays off staff after losing partnerships

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Dewpoint Therapeutics lays off staff after losing partnerships

Novavax promises a turnaround & Lilly roils the obesity market

EU regulator recommends expanding Mounjaro approval to obesity

explore

Test for long Covid? Researchers find new clue in blood samples

STAT Readout Newsletter: Today's biggest biotech updates

Eli Lilly, Pfizer, and others want in on the online prescription market

How digital therapeutics firms are pivoting after Pear's bankruptcy

2023 STAT Wunderkinds: get to know the winners

Impact of Dobbs ruling felt at reproductive medicine meeting

explore

focus

knowledge

Wikipedia